Global Information
회사소개 | 문의 | 비교리스트

세계의 지루성각화증 치료 시장(2019-2023년)

Global Seborrheic Keratosis Treatment Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 03월 상품 코드 823142
페이지 정보 영문 112 Pages
가격
US $ 2,500 ₩ 3,122,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,746,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,995,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,244,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 지루성각화증 치료 시장(2019-2023년) Global Seborrheic Keratosis Treatment Market 2019-2023
발행일 : 2019년 03월 페이지 정보 : 영문 112 Pages

노년 인구의 급증에 의해 향후 수년간 지루성각화증 치료(Seborrheic Keratosis Treatment) 시장이 크게 성장할 전망입니다. 의료시설의 급속한 발전과 첨단 치료법의 옵션에 의해 고령자의 평균수명은 한층 더 연장되고 있습니다. 지루성각화증 등 건강 상태에 관한 인식의 향상도 향후 수년간 지루성각화증 치료 시장의 수요를 촉진할 전망입니다. Technavio의 애널리스트는 세계의 지루성각화증 치료 시장이 2023년까지 6% 이상의 CAGR로 성장할 것으로 예측했습니다.

세계의 지루성각화증 치료 시장에 대해 조사분석했으며, 시장 규모와 성장률, 시장 동향, 시장 성장 촉진요인·과제, 시장 기회 검증 및 주요 벤더 등에 관한 정보를 정리하여 전해드립니다.

제1장 개요

제2장 리포트의 범위

  • 서론 1
  • 서론 2
  • 달러의 통화 환산율

제3장 시장 상황

  • 시장 에코시스템
  • 시장의 특징
  • 시장 세분화 분석

제4장 시장 규모

  • 시장의 정의
  • 시장 규모(2018년)
  • 시장 규모 및 예측(2018-2023년)

제5장 Five Forces 분석

  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 신규 진출의 위협
  • 대체품의 위협
  • 경쟁 상대의 위협
  • 시장 현황

제6장 시장 세분화 : 종류별

  • 시장 세분화 : 종류별
  • 비교 : 종류별 시장 규모 및 예측(2018-2023년)
  • 냉동요법
  • 전기 소작기
  • 기타 치료법
  • 시장 기회 : 종류별

제7장 고객 상황

제8장 지역 상황

  • 지역별 세분화
  • 지역별 비교 : 시장 규모 및 예측(2018-2023년)
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 시장 기회

제9장 성장요인과 과제

  • 시장 성장요인
  • 시장이 해결해야 할 과제

제10장 시장 동향

제11장 벤더 구도

  • 개요
  • 창조적 파괴 상황
  • 경쟁 시나리오

제12장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Aclaris Therapeutics, Inc.
  • Brymill Cryogenic Systems
  • CryoConcepts LP
  • OLYMPUS CORPORATION
  • Special Medical Technology Co., Ltd.

제13장 부록

  • 조사 방법
  • 약어 리스트
KSA 19.04.19

About this market

The surge in geriatric population will lead the seborrheic keratosis treatment market to witness considerable growth in the forthcoming years. Rapid developments in the healthcare facilities and advanced treatment options have further resulted in increasing the life expectancy of the geriatric population. Rising awareness about the health conditions including seborrheic keratosis will also drive the demand for seborrheic keratosis treatment market during the next few years. Technavio's analysts have predicted that the seborrheic keratosis market will register a CAGR of over 6% by 2023.

Market Overview

High prevalence of seborrheic keratosis

One of the growth drivers of the global seborrheic keratosis market is the high prevalence of seborrheic keratosis. The increasing awareness about health and the importance of sports is increasing the prevalence of skin conditions, including seborrheic keratosis.

Challenges associated with misdiagnosis

One of the challenges in the growth of the global seborrheic keratosis market is the challenges associated with misdiagnosis. The lack of medical devices for the diagnosis coupled with the camouflaging nature of the symptoms and signs leads to misdiagnosis, which will hamper the market growth.

For the detailed list of factors that will drive and challenge the growth of the seborrheic keratosis market during 019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several market players. Vendors in the market are increasingly focusing on technological advances in cryotherapy equipment that help in the visualization of the cryotherapy experience with thermal imaging. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Cryotherapy - Market size and forecast 2018-2023
  • Electrocautery - Market size and forecast 2018-2023
  • Other treatments - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aclaris Therapeutics, Inc.
  • Brymill Cryogenic Systems
  • CryoConcepts LP
  • OLYMPUS CORPORATION
  • Special Medical Technology Co., Ltd.

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by type
  • Exhibit 19: Cryotherapy - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Cryotherapy - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Electrocautery - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Electrocautery - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Other treatments - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Other treatments - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by type
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Top 3 countries in North America
  • Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Top 3 countries in Europe
  • Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Top 3 countries in Asia
  • Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Top 3 countries in ROW
  • Exhibit 41: Market opportunity
  • Exhibit 42: Growth in geriatric population 2013-2017 (%)
  • Exhibit 43: Impact of drivers and challenges
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Aclaris Therapeutics, Inc. - Vendor overview
  • Exhibit 50: Aclaris Therapeutics, Inc. - Business segments
  • Exhibit 51: Aclaris Therapeutics, Inc. - Organizational developments
  • Exhibit 52: Aclaris Therapeutics, Inc. - Segment focus
  • Exhibit 53: Aclaris Therapeutics, Inc. - Key offerings
  • Exhibit 54: Aclaris Therapeutics, Inc. - Key customers
  • Exhibit 55: Brymill Cryogenic Systems - Vendor overview
  • Exhibit 56: Brymill Cryogenic Systems - Key offerings
  • Exhibit 57: Brymill Cryogenic Systems - Key customers
  • Exhibit 58: CryoConcepts LP - Vendor overview
  • Exhibit 59: CryoConcepts LP - Key offerings
  • Exhibit 60: CryoConcepts LP - Key customers
  • Exhibit 61: OLYMPUS CORPORATION - Vendor overview
  • Exhibit 62: OLYMPUS CORPORATION - Business segments
  • Exhibit 63: OLYMPUS CORPORATION - Organizational developments
  • Exhibit 64: OLYMPUS CORPORATION - Geographic focus
  • Exhibit 65: OLYMPUS CORPORATION - Segment focus
  • Exhibit 66: OLYMPUS CORPORATION - Key offerings
  • Exhibit 67: OLYMPUS CORPORATION - Key customers
  • Exhibit 68: Special Medical Technology Co., Ltd. - Vendor overview
  • Exhibit 69: Special Medical Technology Co., Ltd. - Key offerings
  • Exhibit 70: Special Medical Technology Co., Ltd. - Key customers
  • Exhibit 71: Validation techniques employed for market sizing
Back to Top
전화 문의
F A Q